Related Experiment Video
Updated: May 17, 2026
09:36
RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
Published on: April 10, 2018
Long noncoding RNAs as sinks in Prader-Willi syndrome
Kathleen L McCann1, Susan J Baserga
1Department of Genetics, Yale University School of Medicine, New Haven, CT 06520, USA.
Molecular Cell
|October 30, 2012
Summary
Researchers discovered novel long noncoding RNAs (lncRNAs) that offer new insights into the molecular mechanisms driving Prader-Willi syndrome. This finding advances our understanding of lncRNA roles in genetic disorders.
Area of Science:
- Genetics
- Molecular Biology
- Developmental Biology
Background:
- Prader-Willi syndrome is a complex genetic disorder affecting development and metabolism.
- The genetic underpinnings of Prader-Willi syndrome are not fully understood, particularly the role of non-coding RNAs.
- Long noncoding RNAs (lncRNAs) are increasingly recognized for their regulatory functions in gene expression and disease.
Discussion:
- Yin et al. identify a specific class of lncRNAs implicated in Prader-Willi syndrome pathogenesis.
- The study proposes a novel mechanism by which these lncRNAs contribute to the disease.
- This research sheds light on the complex molecular pathways involved in Prader-Willi syndrome.
Key Insights:
- Identification of a novel class of lncRNAs associated with Prader-Willi syndrome.
- Elucidation of a new pathogenic mechanism involving lncRNAs in this genetic disorder.
- Contribution to the understanding of lncRNA function in neurodevelopmental and metabolic diseases.
Outlook:
- Further investigation into the precise functions of these lncRNAs.
- Potential for developing novel therapeutic strategies targeting lncRNAs for Prader-Willi syndrome.
- Expanding the role of lncRNAs in the pathogenesis of other genetic disorders.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:57piRNA - Piwi-interacting RNAs
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
03:18Non-LTR Retrotransposons
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...